Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns
NCT00006058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2005-06-24
Summary
OBJECTIVES:
I. Create a clinical sample bank of neonates with lung disease to test hypotheses regarding the pathogenesis of bronchopulmonary dysplasia (BPD).
II. Determine whether a developmental deficiency of surfactant protein B (SP-B) contributes to the occurrence of respiratory distress and BPD in these patients.
III. Study metabolic abnormalities associated with inherited deficiency of SP-B in these patients.
IV. Determine whether plasma nitrotyrosine levels, a marker of peroxynitrite mediated oxidant stress, are elevated in premature infants who develop BPD.
V. Measure the temporal changes in critical components of the inflammatory process (cell composition, inducible nitric oxide synthase, hyaluronan (HA), receptor for HA mediated mobility, and selected cytokines) in bronchoalveolar lavage, blood, and urine samples obtained from these patients, and to correlate these changes with their clinical course.
VI. Examine changes in the insulin-like growth factor axis that occur in the lungs of infants with respiratory distress syndrome (RDS) and BPD.
VII. Determine the relationship between degradation of elastin and the clinical course of BPD.
VIII. Determine whether the normal fall in plasma endothelin-1 concentrations after birth are delayed in infants with RDS and BPD.
Conditions
- Respiratory Distress Syndrome
- Bronchopulmonary Dysplasia
Sponsors & Collaborators
-
Children's Hospital of Philadelphia
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Roberta A. Ballard · Children's Hospital of Philadelphia
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-09-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Interventions in Respiratory Distress Syndrome and Neonatal Lung Injury - SCOR in Lung Biology and Diseases in Infants and Children
NCT00005683 ·Status: COMPLETED
-
Genetic Regulation of Surfactant Deficiency
NCT00828243 ·Status: COMPLETED
-
MRI in BPD Subjects
NCT03657693 ·Status: RECRUITING
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
NCT06475976 ·Status: RECRUITING
-
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
NCT01607216 ·Status: COMPLETED
-
Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
NCT04890158 ·Status: TERMINATED ·Phase: NA
-
The Baby Lung Study
NCT05152316 ·Status: COMPLETED
-
Stem Cells for Bronchopulmonary Dysplasia
NCT03378063 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
NCT01748565 ·Status: COMPLETED
-
Analysis of BPD in Premature Infants With Typical Imaging Changes
NCT04163822 ·Status: COMPLETED
-
Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China
NCT03850457 ·Status: COMPLETED
-
Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia
NCT05986032 ·Status: RECRUITING
-
Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
NCT01039285 ·Status: COMPLETED ·Phase: PHASE4
-
Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia in Preterm Babies
NCT02443961 ·Status: COMPLETED ·Phase: PHASE1
-
Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome
NCT02333669 ·Status: COMPLETED
-
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
NCT03542812 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Impact of Extended CPAP on Bronchopulmonary Dysplasia
NCT05547139 ·Status: COMPLETED ·Phase: NA
-
Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease
NCT05898633 ·Status: COMPLETED ·Phase: PHASE1
-
Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
NCT04941963 ·Status: COMPLETED
-
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
NCT01516398 ·Status: COMPLETED
-
Fluid Restriction in Respiratory Distress of the Newborn
NCT03120585 ·Status: COMPLETED ·Phase: NA
-
Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
NCT01644981 ·Status: COMPLETED
-
Comparison of Classification Standards of Bronchopulmonary Dysplasia (BPD) in Premature Infants
NCT04184648 ·Status: COMPLETED
-
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
NCT02527798 ·Status: COMPLETED ·Phase: PHASE2
-
p16Ink4a in Bronchopulmonary Dysplasia in Children
NCT03540680 ·Status: UNKNOWN ·Phase: NA